Search

uniQure NV

Abierto

22.37 -3.2

Resumen

Variación precio

24h

Actual

Mínimo

22.35

Máximo

23.24

Métricas clave

By Trading Economics

Ingresos

-28M

-81M

Ventas

2.3M

5.8M

BPA

-1.22

Margen de beneficios

-1,387.759

Empleados

221

EBITDA

-34M

-70M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+135.52% upside

Dividendos

By Acuity

Próximas Ganancias

9 nov 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-1B

1.6B

Apertura anterior

25.57

Cierre anterior

22.37

uniQure NV Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

7 oct 2026, 23:55 UTC

Dexcom Inc's shares have declined in after-market trading, settling lower after an early high and remaining below their 20-day moving average.

7 oct 2026, 23:55 UTC

News

Aptiv PLC shares traded modestly lower in after-hours action following UBS's Buy rating and a lowered price target of $57.

7 oct 2026, 23:55 UTC

StoneX Group Inc's shares are trading modestly higher in after-market hours, despite a decline during the regular session and remaining below its 20-day moving average.

7 oct 2026, 23:55 UTC

Krispy Kreme Inc. is up in after-market trading, reaching a peak return after gaining ground since Wednesday's close, despite being 2.12% below its 20-day moving average.

7 oct 2026, 23:55 UTC

In after-market trading, Dycom Industries Inc is roughly flat since Wednesday's close, reflecting routine market behavior and remaining near the middle of its one-month range.

7 oct 2026, 23:55 UTC

Geo Group Inc is trading modestly lower in after-market hours, remaining below its 20-day moving average and near the lower end of its one-month range.

7 oct 2026, 23:51 UTC

ETF Constituents

The fund advanced in after-market trading, driven by significant gains in AXTI, AEHR, LITE, SMTC, and TSEM, and is above its 20-day moving average.

7 oct 2026, 23:51 UTC

Preferred Bank is experiencing a notable decline in after-market trading, with shares significantly below their 20-day moving average following Wednesday's close.

7 oct 2026, 23:51 UTC

Mueller Industries Inc. is trading lower in after-market hours, continuing its decline and remaining near the lower end of its one-month range.

7 oct 2026, 23:51 UTC

CVS Health Corp is trading modestly higher in after-market hours, with a cumulative return of 0.61% following Wednesday's close.

7 oct 2026, 23:51 UTC

Innoviva Inc has advanced in after-market trading, gaining ground since Wednesday's close and remaining above its 20-day moving average.

7 oct 2026, 23:51 UTC

O'Reilly Automotive Inc. is trading modestly higher in after-market hours, supported by significant gains in the automotive retail sector.

7 oct 2026, 23:51 UTC

Ginkgo Bioworks Holdings Inc is trading lower in after-market hours, marking its third consecutive session of declines following a significant dip earlier in the day.

7 oct 2026, 23:51 UTC

Novavax Inc's shares are trading modestly lower in after-market hours, continuing a trend of three consecutive daily declines despite remaining above the 20-day moving average.

7 oct 2026, 23:51 UTC

News

Hilton Worldwide Holdings Inc is trading modestly lower in after-market hours, breaking a recent trend of higher daily closes amid broader market shifts.

7 oct 2026, 23:51 UTC

Martin Marietta Materials Inc is trading modestly lower in after-market hours, having reversed an initial rise and remaining below its 20-day moving average.

7 oct 2026, 23:51 UTC

Lowe's Companies Inc has advanced modestly in after-market trading, despite trading below its 20-day moving average and near the lower end of its one-month range.

7 oct 2026, 23:51 UTC

Correlated Moves

Brixmor Property Group Inc is trading higher in after-market hours, reflecting notable gains since Wednesday's close, amid rising shares of W.P. Carey Inc.

7 oct 2026, 23:51 UTC

UK Housing Market Weakens as RICS Reports House Price Balance Falls to -0.32%, Heightening Investor Concerns Amid Economic Pressures

7 oct 2026, 23:51 UTC

RBA Meeting Minutes Set for October 13, Amid Speculation of Interest Rate Hike and Mixed Economic Signals in Australia.

7 oct 2026, 23:51 UTC

Australia's NAB Business Confidence report set for October 13 amid cautious pre-release expectations due to declining consumer sentiment and rising operational costs.

7 oct 2026, 23:51 UTC

Japan's Machinery Orders Data Release on October 14, 2026, Expected to Influence Capital Spending Insights Amid Mixed Economic Sentiment.

7 oct 2026, 23:50 UTC

Coty Inc. has advanced in after-market trading, continuing its upward momentum with notable gains following six consecutive sessions of increases.

7 oct 2026, 23:50 UTC

Abbott Laboratories is trading slightly higher in after-market hours, following a modest earlier session increase, though it remains below its 20-day moving average.

7 oct 2026, 23:50 UTC

Maximus Inc is trading modestly higher in after-market hours, continuing an upward trend and reaching its highest cumulative return since Wednesday's close.

7 oct 2026, 23:50 UTC

Mastercard Inc shares are trading lower in after-market hours, diverging from a recent trend of higher daily closes.

7 oct 2026, 23:50 UTC

Old Dominion Freight Line Inc. traded modestly higher in after-market hours, despite settling slightly lower from Wednesday's close amid broader market declines.

7 oct 2026, 23:50 UTC

IES Holdings Inc. has advanced modestly in after-market trading, recovering from earlier lows but remains below its 20-day moving average.

7 oct 2026, 23:50 UTC

Fidelity National Information Services Inc saw a modest increase in after-market trading, recovering from earlier losses but remains below its 20-day moving average.

7 oct 2026, 23:50 UTC

HP Inc. is trading modestly higher in after-market hours, reaching its highest cumulative return since Wednesday's close, with steady gains throughout the session.

Comparación entre iguales

Cambio de precio

uniQure NV previsión

Precio Objetivo

By TipRanks

135.52% repunte

Estimación a 12 Meses

Media 54.5 USD  135.52%

Máximo 80 USD

Mínimo 28 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para uniQure NV Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

9 ratings

7

Comprar

2

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de uniQure NV

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases. It offers HEMGENIX that has completed Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also develops AMT-130, a gene therapy that is in Phase I/II clinical study for the treatment of Huntington's disease. In addition, it is developing AMT-162, which is in preclinical trial for the treatment of superoxide dismutase 1- amyotrophic lateral sclerosis; AMT-260 that is in preclinical trial to treat temporal lobe epilepsy; AMT-191, which is in preclinical trial for the treatment of fabry disease; AMT-161 that is in preclinical trial to treat amyotrophic lateral sclerosis caused by mutations; AMT-240, which is in preclinical trial to for the treatment of autosomal dominant Alzheimer's disease; and AMT-210 that is in preclinical trial to treat Parkinson's disease. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands.